Announcements Trials
Browse Landscape

Phase

Phase 2/3 3Phase 1/2 1

Status

Completed 65Terminated 49Recruiting 27Active not recruiting 23Withdrawn 6Unknown 6Not yet recruiting 4Suspended 1Approved for marketing 1

Sponsor Class

OTHER 22INDUSTRY 4NETWORK 2NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4

Conditions

Leukemia, Myeloid, Acute 4

Interventions

Injections 39Carboplatin 33Capecitabine 24Paclitaxel 23Cisplatin 23Docetaxel 22pembrolizumab 21Oxaliplatin 21Gemcitabine 21Bevacizumab 19Pemetrexed 18Fluorouracil 13Irinotecan 12Cyclophosphamide 11osimertinib 9Nivolumab 9Dexamethasone 8Topotecan 7Leucovorin 7130-nm albumin-bound paclitaxel 7venetoclax 6toripalimab 6tislelizumab 6regorafenib 6lenvatinib 6fludarabine 6Doxorubicin 6Cetuximab 6daratumumab 5atezolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × INDUSTRY × Azacitidine × Clear all
NCT07623187 2026-06-03

EVICTION 3

Ipsen

Phase 2/3 Not yet recruiting
450 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07581002 2026-05-12

REVIVAL

AbbVie

Phase 2/3 Not yet recruiting
660 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07255872 2026-03-05

A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 2/3 Not yet recruiting
216 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06387420 2024-04-29

A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia

Akeso

Phase 1/2 Not yet recruiting
180 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡